In support of this model, new findings have demonstrated that Orai3 expression is increased in CD4+ T cells from patients with rheumatoid arthritis and psoriatic arthritis and that silencing of Orai3 reduces tissue inflammation in a human synovium adoptive transfer model (Ye et al., 2021). Here, CD4 is linked to rheumatoid arthritis.